ethyl-3-methyl-5-cyanoindole-2-carboxylate | 169463-45-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: ethyl-3-methyl-5-cyanoindole-2-carboxylate
• 英文别名: Ethyl 5-cyano-3-methyl-1H-indole-2-carboxylate
• CAS: 169463-45-0
• 化学式: C₁₃H₁₂N₂O₂
• 分子量: 228.25
• InChiKey: FGYYDGOAFTUGFE-UHFFFAOYSA-N

物化性质

• 沸点：
  416.7±40.0 °C(Predicted)
• 密度：
  1.25±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  65.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ethyl-3-methyl-5-cyanoindole-2-carboxylate 在 4-二甲氨基吡啶 、 lithium hydroxide 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 N,N-二异丙基乙胺 作用下， 生成 methyl 7-[(5-cyano-3-methyl-1H-indole-2-carbonyl)amino]heptanoate
  参考文献：
  名称：

  Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists

  摘要：

  The use of 5,6-bicyclic amidines as arginine surrogates in the design of a novel class of potent platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists is described. The additional conformational restriction offered by the bicyclic nucleus results in 20-400-fold increases in potency compared to the freely flexible, acyclic benzamidine counterpart. The design, synthesis, structure-activity relationships (SAR), and in vitro activity of this novel class of GPIIb-IIIa antagonists are presented.

  DOI：

  10.1021/jm970020k
• 作为产物：
  描述：

  3-甲基-4-硝基苯甲腈 在 sodium 、 sodium hydride 、 溶剂黄146 、 锌 作用下， 以 乙醇 为溶剂， 生成 ethyl-3-methyl-5-cyanoindole-2-carboxylate
  参考文献：
  名称：

  Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists

  摘要：

  The use of 5,6-bicyclic amidines as arginine surrogates in the design of a novel class of potent platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists is described. The additional conformational restriction offered by the bicyclic nucleus results in 20-400-fold increases in potency compared to the freely flexible, acyclic benzamidine counterpart. The design, synthesis, structure-activity relationships (SAR), and in vitro activity of this novel class of GPIIb-IIIa antagonists are presented.

  DOI：

  10.1021/jm970020k

文献信息

• [EN] AROMATIC AMIDINE DERIVATIVES USEFUL AS SELECTIVE THROMBIN INHIBITORS<br/>[FR] DERIVES D'AMIDINE AROMATIQUE UTILES EN TANT QU'INHIBITEURS SELECTIFS DE LA THROMBINE
  申请人：C & C RESEARCH LABORATORIES

  公开号：WO1997045424A1

  公开（公告）日：1997-12-04

  (EN) The present invention relates to a novel thrombin inhibitor which is effective even when orally administered. More specifically, the present invention relates to an aromatic amidine derivative represented by formula (I) and the salts thereof, which show potent selective inhibitory activity for thrombin in which (a), R, R1, R2, R3, A, W, Y and n are defined as described in the specification.(FR) L'invention concerne un nouvel inhibiteur de la thrombine qui est efficace même lorsqu'il est administré par voie orale. Plus spécifiquement, l'invention concerne un dérivé d'amidine aromatique représenté par la formule (I) et des sels de celle-ci, qui présentent une activité inhibitrice sélective pour la thrombine. Dans ladite formule, (a), R, R1, R2, R3 A, W, Y et n sont définis comme décrits dans la spécification.

  本发明涉及一种新型的抑制凝血酶的药物，即使口服也具有有效性。更具体地说，本发明涉及一种芳香基脒衍生物及其盐，其在(a)、R、R1、R2、R3、A、W、Y和n如规范所述的情况下，对凝血酶具有强有力的选择性抑制活性。
• 5,6-Bicyclic glycoprotein IIb IIIa antagonists useful in inhibition of platelet aggregation
  申请人：ELI LILLY AND COMPANY

  公开号：EP0655439A2

  公开（公告）日：1995-05-31

  This invention relates to 5,6 fused ring bicyclic compounds inclusive of indoles, benzofurans, and benzothiophenes, and corresponding to the formula (I) substituted with both basic (B) and acidic (A) functionality, which are useful in inhibition of platelet aggregation.

  本发明涉及包括吲哚、苯并呋喃和苯并噻吩在内的5,6融合环双环化合物，并对应于式(I) 被碱性（B）和酸性（A）官能团取代，可用于抑制血小板聚集。
• AROMATIC AMIDINE DERIVATIVES USEFUL AS SELECTIVE THROMBIN INHIBITORS
  申请人：C & C Research Laboratories

  公开号：EP0918768A1

  公开（公告）日：1999-06-02
• Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists
  作者：Daniel J. Sall、Ann E. Arfsten、Jolie A. Bastian、Michael L. Denney、Cathy S. Harms、Jefferson R. McCowan、John M. Morin,、Jack W. Rose、Robert M. Scarborough、Mark S. Smyth、Suzane L. Um、Barbara G. Utterback、Robert T. Vasileff、James H. Wikel、Virginia L. Wyss、Joseph A. Jakubowski

  DOI：10.1021/jm970020k

  日期：1997.8.1

  The use of 5,6-bicyclic amidines as arginine surrogates in the design of a novel class of potent platelet glycoprotein IIb-IIIa receptor (GPIIb-IIIa) antagonists is described. The additional conformational restriction offered by the bicyclic nucleus results in 20-400-fold increases in potency compared to the freely flexible, acyclic benzamidine counterpart. The design, synthesis, structure-activity relationships (SAR), and in vitro activity of this novel class of GPIIb-IIIa antagonists are presented.